Buckshot26 wrote: Thank you for the respectful reply, I will do the same.
I beleive Cannimed is a joke so I completely concur with your assessment of them. There are those that believe that their labs and extraction facilities are valuable but I can't value something I don't know and therefore still can't believe ACB paid just over a billion for it. For that and other reasons before then I have not owned ACB since selling it back on that amazing blow off top Novemeber 16th, 2016.
LEAF on the other hand has long been regarded by the people I speak to as the smartmoney play. It had next to no retail following with almost all shares held by it's founders, Institutions and Hedge Funds. Without a single acquisition they were able to grow themselves organically into the number 3 LP in Canada in terms of revenues. Last qtr they did just over 11.35m in sales vs canopy's 21.7m. There are currently only 5 LP's in Canada doing over $5m in quaterly sales, the other being Aurora $16.1m , Aphria $10.3m and Canntrust $7.8m.
I think you are showing a real bias with a statement like you made saying the LEAF acquisition is not big. The number 2 bought the number 3 to become the new number 1. We can kick and scream all we want but this is fact. The combined ACB-LEAF recorded $27.45m in revenues versus Canopy's $21.7.
Next your arguement is flawed in that you state that Canopy has the capital to do a $4B acquisition abroad. You can't use paper (campany shares) to buy a publicly traded company in other countries. Once listed in NY they could potentially leverage Canopy paper for an American asset but no one in Europe etc is going to accept shares of a Canadian listed company in exchange for their shares. A deal outside of North America of any size will require cash.
How do you support your assertion that Canopy is number 1 and the race is over. Given they have almost identicle capacity and ACB-LEAF has 25% more revenues it sounds a lot like an opinion more than a fact.
55orbust wrote: Buckshot, I totally agree with that statement. However, I don't agree with the fact that Cannimed and Leaf are big acquisitions. I think the price paid for them was big but the acquisitions themselves were not. I realize you have a position I Aurora but please don't ruin your credibility defending these horrendous acquisition prices. How do you defend the "Secret Sauce" comment. If Canopy spent 4 billion dollars, which they eventually will do but not in Canada, let's be real and agree that Aurora could not keep up. While Aurora grossly over pays trying to catch up to Canopy in Canada, I can assure you that Canopy is building relationships and looking for the right(priced) acquisitions to make globally. The race for number 1 is over. Aurora needs to assimilate these acquisitions and try to make the best of them.
Buckshot26 wrote: Two lessons to be learned from this wikipedia entry, most of which is written on sh is absolute unsubstantiated bs and second big companies become industry leading giants through big acquisitions.
[url=https://en.wikipedia.org/wiki/Foster's_Group]wikipedia fosters group[/url]
investor1964 wrote: Has anyone ever been able to find out if Australia allows a full buyout of their corporations? I know it was rumored that Aurora was considering a buyout of Cann Group in Australia then that rumor died - I wonder if it was because they found out they couldnt? I agree it would be a good idea for Bruce to buy out Auscann if he can!
dirkdiggler3 wrote: Bruce said he will growth organically and not buy any canadian LP and i think it is fine. So we have some near term catalysts (NYSE,7 th june etc) and the sp should increase considerably. I think after the big run up it might be the right time to take over Ausscan and make it our platform for developing the Asia-Pacific region.This being done,they will have to stay on the lookout for opportunities in europe and especially be ready for usa. Just my thoughts,sorry for my english.
https://www.newcannabisventures.com/canopy-growth-acquires-german-medical-cannabis-company-medcann-gmbh/